Clinical trial
Cervical Cancer Screening Among HIV-infected Women in Western Kenya: Evaluation of the Safety, Acceptability, and Efficacy of an Alternative Ablation Method for Treatment of Precancerous Lesions
NCT04191967 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cervical Cancer Screening Among HIV-infected Women in Western Kenya: Evaluation of the Safety, Acceptability, and Efficacy of an Alternative Ablation Method for Treatment of Precancerous Lesions
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 25, 2019
- Completion date
- November 30, 2021
- Enrollment
- 379 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cin 2/3, hpv infection, human immunodeficiency virus